N.g.industries Ltd.
BSE: NGIND · Healthcare Service Provider · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1 cr vs borrowings ₹2 cr (FY26): borrowings are higher by ₹0 cr.
- Operating profit covered interest 38.4x in the last 12 months.
- Net loss in 1 of the last 6 quarters.
- Other income was 59% of net profit in the last 12 months.
- Dividend paid in 4 of the last 5 financial years.
- Price ₹102.50 on 2026-10-26: -35.9% from the 52-week high, +3.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 4 | 4 | 4 | 4 | 4 | 4 |
| EBITDA | 1 | 0 | 0 | 0 | 1 | 0 |
| OPM % | 12.1% | 8.9% | 7.9% | 11.7% | 14.4% | 10.2% |
| Other income | -3 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -2 | 0 | 0 | 0 | 1 | 0 |
| EPS (₹) | 7.26 | 0.58 | 1.28 | 1.27 | 2.05 | 1.16 |
| Revenue YoY | -2.5% | +13.8% | ||||
| Profit YoY | – | +105.3% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 18 | 19 | 17 | 17 | 16 | 17 |
| EBITDA | 2 | 2 | 2 | 2 | 2 | 2 |
| Net profit | 3 | 8 | 5 | 8 | 2 | 2 |
| EPS (₹) | 7.79 | 24.82 | 15.02 | 23.10 | 5.17 | 5.76 |
| Revenue growth | +1.5% | -9.7% | -2.0% | -1.0% | – | |
| Profit growth | +218.8% | -39.5% | +53.9% | -77.6% | – | |
| Dividend / share (₹) | – | 3.50 | 3.50 | 3.50 | 3.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -4.3% | – | – |
| Net profit | -40.7% | – | – |
| EPS | -40.7% | – | – |
| Share price | – | -21.2% (2y) | -34.4% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 39 | 34 |
| Borrowings | 2 | 2 |
| Cash & equivalents | 3 | 1 |
| Total assets | 42 | 35 |
| Fixed assets | 6 | 5 |
| Capital work in progress | 0 | – |
| Investments | 32 | 26 |
| Receivables | 0 | 0 |
| Inventory | 1 | 1 |
| Payables | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 2 | 1 |
| Cash from investing | -1 | -0 |
| Cash from financing | -1 | -1 |
| Capex | 1 | 0 |
| Free cash flow | 1 | 1 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 20.1% | 5.2% |
| ROCE % | 22.8% | 6.3% |
| Debtor days | 9 | 11 |
| Inventory days | 64 | 70 |
| Payable days | 0 | 0 |
| Cash conversion cycle (days) | 73 | 81 |
| Working capital days | 35 | 59 |
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| NGIND | ₹34 cr | 17.8x | 1.0x | 5.3% | 6.9% | 11.1% | -4.3% | 3.41% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-18 | Dividend | Final Dividend Rs 3.5 |
| 2025-09-19 | Dividend | Final Dividend Rs 3.5 |
| 2024-09-20 | Dividend | Dividend Rs 3.5 |
| 2023-09-22 | Dividend | Dividend Rs 3.5 |
| 2022-09-16 | Dividend | Dividend Rs 3.5 |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | NGIND |
| BSE code | 530897 |
| ISIN | INE825C01018 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.